Search Results

The Effects of a Gluten-Free Diet on Immune Markers and Kynurenic Acid Pathway Metabolites in Patients With Schizophrenia Positive for Antigliadin Antibodies Immunoglobulin G.

• Authors : Friendshuh, C. Renay; Pocivavsek, Ana; Demyonovich, Haley

• Source: Journal of Clinical Psychopharmacology; May/Jun2020, Vol. 40 Issue 3, p317-319, 3p

Record details

Pharmacokinetics and Safety Assessment of l-Tetrahydropalmatine in Cocaine Users: A Randomized, Double-Blind, Placebo-Controlled Study.

• Authors : Hassan, Hazem E.; Kelly, Deanna; Honick, Moshe

Subjects: COCAINE; NARCOTIC antagonists; PLACEBOS

• Source: Journal of Clinical Pharmacology; Feb2017, Vol. 57 Issue 2, p151-160, 10p

Record details

Predictors of the Perception of Smoking Health Risks in Smokers With or Without Schizophrenia.

• Authors : Kowalczyk, William J.; Wehring, Heidi J.; Burton, George

Subjects: ATTITUDE (Psychology); DESIRE; DRUG addiction

• Source: Journal of Dual Diagnosis; Jan-Mar2017, Vol. 13 Issue 1, p29-35, 7p

Record details

Antipsychotic Treatment and Tobacco Craving in People With Schizophrenia.

• Authors : Wehring, Heidi J.; Heishman, Stephen J.; McMahon, Robert P.

Subjects: DRUG therapy for schizophrenia; ANTIPSYCHOTIC agents; CLOZAPINE

• Source: Journal of Dual Diagnosis; Jan-Mar2017, Vol. 13 Issue 1, p36-42, 7p

Record details

The Family Value of Information, Community Support, and Experience Study: Rationale, Design, and Methods of a "Family-Centered" Research Study.

• Authors : Reeves, Gloria M.; Wehring, Heidi J.; Connors, Kathleen M.

• Source: Journal of Nervous & Mental Disease; Dec2015, Vol. 203 Issue 12, p896-900, 5p

Record details

Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms.

• Authors : Kelly, Deanna L.; Sullivan, Kelli M.; McEvoy, Joseph P.

• Source: Journal of Clinical Psychopharmacology; Aug2015, Vol. 35 Issue 4, p374-381, 8p

Record details

Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

• Authors : Kelly, Deanna L.; Wehring, Heidi J.; Earl, Amber K.

Subjects: HYPERPROLACTINEMIA; SCHIZOPHRENIA treatment; WOMEN'S mental health

• Source: BMC Psychiatry; 2013, Vol. 13 Issue 1, p1-14, 14p, 1 Chart, 1 Graph

Record details

Peripheral oxytocin and vasopressin are associated with clinical symptom severity and cognitive functioning in midlife women with chronic schizophrenia.

• Authors : Rubin, Leah H.^1,2; Wehring, Heidi J.³; Demyanovich, Haley³

Subjects: *VASOPRESSIN; *COGNITIVE ability; *SCHIZOPHRENIA treatment

• Source: Schizophrenia Research. May2018, Vol. 195, p409-411. 3p.

Record details

A review of anti-inflammatory agents for symptoms of schizophrenia.

• Authors : Keller, William R; Kum, Lionel M; Wehring, Heidi J

Subjects: ANTI-inflammatory agents; SCHIZOPHRENIA; MENTAL illness

• Source: Journal of Psychopharmacology; Apr2013, Vol. 27 Issue 4, p337-342, 6p

Record details

Perception of Smoking Risks and Motivation to Quit Among Nontreatment-Seeking Smokers With and Without Schizophrenia.

• Authors : Kelly, Deanna L.; Raley, Heather G.; Lo, Suzanne

• Source: Schizophrenia Bulletin; May2012, Vol. 38 Issue 3, p543-551, 9p

Record details